LabTurbo Biotech (ROCO:7725) Notes Receivable: NT$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7725 LabTurbo Biotech Corp ROCO:7725
14 GF Score
Price NT$23.00
! 2 Warning Signs
View Full Analysis

What is LabTurbo Biotech Notes Receivable?

LabTurbo Biotech ROCO:7725 14 Notes Receivable is NT$0.00 Mil as of Dec. 2025. GuruFocus rates ROCO:7725 with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

LabTurbo Biotech's Notes Receivable for the quarter that ended in Dec. 2025 was NT$0.00 Mil.

LabTurbo Biotech Notes Receivable Related Terms

LabTurbo Biotech Notes Receivable Historical Data

* Premium members only.

The historical data trend for LabTurbo Biotech's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LabTurbo Biotech Notes Receivable Chart

LabTurbo Biotech Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00 0.00

LabTurbo Biotech Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:7725
14GF Score
LabTurbo Biotech Corp ROCO:7725
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LabTurbo Biotech Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of NT$0.00 Mil mean?
LabTurbo Biotech (ROCO:7725) has a Notes Receivable of NT$0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on LabTurbo Biotech and its competitors.
Is LabTurbo Biotech's Notes Receivable too high?
LabTurbo Biotech's current Notes Receivable is NT$0.00 Mil. Overall, LabTurbo Biotech has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does LabTurbo Biotech's Notes Receivable compare to VRTX and REGN?
LabTurbo Biotech's Notes Receivable of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on LabTurbo Biotech and its competitors. LabTurbo Biotech's current Notes Receivable is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LabTurbo Biotech stock overvalued right now?
LabTurbo Biotech (ROCO:7725) has a current Notes Receivable of NT$0.00 Mil. The current Notes Receivable is NT$0.00 Mil. LabTurbo Biotech's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For LabTurbo Biotech (ROCO:7725), the current Notes Receivable is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LabTurbo Biotech Business Description

Address 3F-1, No. 150, Section 4, Chengde Road, Shilin District, Taipei, TWN
LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.
14GF Score

Get the complete analysis for ROCO:7725

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$23.00
Price